Angelman syndrome (AS) is a rare neurogenetic disorder caused by the loss or malfunction of the UBE3A gene on the maternal chromosome 15. It affects approximately 1 in 15,000 people.
Individuals with AS typically experience developmental delays, severe speech impairment, movement and balance challenges, sleep disturbances, and seizures—but they are also known for their joyful personalities and frequent laughter. While life expectancy is near typical, ongoing care and specialized therapies are essential for improving quality of life.
The Angelman Syndrome Foundation is the leading nonprofit dedicated to improving the lives of individuals with AS and their families through research funding, education, advocacy, and community support. Their goals are advancing awareness, education, support, and research toward treatments and a cure for Angelman syndrome.
What They Do:
• Research: Over $17 million invested in studies driving progress toward treatments and a cure.
• ASF Clinics: Provide coordinated, specialized care through a network of clinics that understand the unique needs of individuals with AS.
• Family Fund: Offers financial assistance for equipment, therapies, and services that enhance quality of life.
• Education & Resources: Webinars, toolkits, and family guides to support caregivers and professionals.
• Community Engagement: Angelman Strong events unite families nationwide to raise awareness and build community.
Impact:
• Global network of multidisciplinary clinics
• Direct support for thousands of families worldwide
• Recognized by national rare disease organizations for transparency, leadership, and impact
Here is a list of conditions this partner raises awareness and advocacy for:
Angelman syndrome begins at birth and although symptoms vary, most children exhibit common developmental delays such as: • Infants showing an inability to support their
Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we
In some cases, healthcare providers can identify Angelman syndrome in utero through a prenatal ultrasound or prenatal genetic testing. But could this open the door
Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on
February 15th is recognized annually as International Angelman Day, a day dedicated around the world to spreading awareness among the general public and in the
Right now, there are no disease-specific treatments or cures for Angelman syndrome, a rare neurogenetic syndrome. Research centers around exploring options to reduce seizures,
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
